Position
Fidelity in Gilead Sciences, Inc.
Back to the book · All holders of GILD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$871.3M$139.37 → $126.34
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 65.6M | $8.05B | — | — | — | 0.4% |
| Q1 2026 | 71.9M | $10B | $139.37 | $1.09B | $881.8M | 0.5% |
| Q2 2026 | 66.9M | $8.45B | $126.34 | −$871.3M | −$701.8M | 0.4% |